Other Species / Isoforms
  EFS (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S20-p
LYDNTAEsPQELSFR
0 2
EFS (human) LYDNTAEsPQELSFR S20-p
EFS iso2 (human) gap -
EFS (mouse) LYDNTAEsPQELSFR S20-p
EFS (rat) LYDNTAESPQELSFR S20
P121
GPPAGPCPPsPDLIy
0 15
EFS (human) GPPAGPCPPsPDLIy P121
EFS iso2 (human) GPPAGPCPPsPDLIY P28
EFS (mouse) GLPARSCsPSSDSIy S121-p
EFS (rat) GLPARSCsPSsDSIy S122-p
S123-p
PAGPCPPsPDLIyKI
0 5
EFS (human) PAGPCPPsPDLIyKI S123-p
EFS iso2 (human) PAGPCPPsPDLIYKI S30-p
EFS (mouse) PARSCsPSSDSIyKV S123
EFS (rat) PARSCsPSsDSIyKV S124
P124
AGPCPPsPDLIyKIP
0 1
EFS (human) AGPCPPsPDLIyKIP P124
EFS iso2 (human) AGPCPPsPDLIYKIP P31
EFS (mouse) ARSCsPSSDSIyKVP S124
EFS (rat) ARSCsPSsDSIyKVP S125-p
Y128-p
PPsPDLIyKIPRASG
0 23
EFS (human) PPsPDLIyKIPRASG Y128-p
EFS iso2 (human) PPsPDLIYKIPRASG Y35
EFS (mouse) sPSSDSIyKVPRGNG Y128-p
EFS (rat) sPSsDSIyKVPRVNG Y129-p
Y148-p
PRDALEVyDVPPTAL
0 10
EFS (human) PRDALEVyDVPPTAL Y148-p
EFS iso2 (human) PRDALEVYDVPPTAL Y55
EFS (mouse) SRDVAEVYDVPPNIL Y148
EFS (rat) PRDVGEVyDVPPNIL Y149-p
S160-p
TALRVPSsGPyDCPA
0 2
EFS (human) TALRVPSsGPyDCPA S160-p
EFS iso2 (human) TALRVPSSGPYDCPA S67
EFS (mouse) NILRAPSSCPYDSPA S160
EFS (rat) NILRAPSNCPYDSPA N161
Y163-p
RVPSsGPyDCPASFS
Upstream
0 59
Treatment
  • FGF2
EFS (human) RVPSsGPyDCPASFS Y163-p
EFS iso2 (human) RVPSSGPYDCPASFS Y70
EFS (mouse) RAPSSCPYDSPASFS Y163
EFS (rat) RAPSNCPYDSPASFS Y164
Y188-p
PGEDDAPyDVPLtPK
0 3
EFS (human) PGEDDAPyDVPLtPK Y188-p
EFS iso2 (human) PGEDDAPYDVPLTPK Y95
EFS (mouse) PREDEAPYDVPLALK Y188
EFS (rat) PGEDEAPYDVPLALK Y189
T193-p
APyDVPLtPKPPAEL
0 1
EFS (human) APyDVPLtPKPPAEL T193-p
EFS iso2 (human) APYDVPLTPKPPAEL T100
EFS (mouse) APYDVPLALKPPAEL A193
EFS (rat) APYDVPLALKSPAEM A194
Y217-p
REPGPPIyAAPSNLK
0 4
EFS (human) REPGPPIyAAPSNLK Y217-p
EFS iso2 (human) REPGPPIYAAPSNLK Y124
EFS (mouse) REPGPPLYAAPSNLK Y217
EFS (rat) REPGPPLYAAPSNLK Y218
Y233
ASALLNLYEAPEELL
0 1
EFS (human) ASALLNLYEAPEELL Y233
EFS iso2 (human) ASALLNLYEAPEELL Y140
EFS (mouse) ASALLNLYEAPEELL Y233
EFS (rat) ASALLNLyEAPEELL Y234-p
S287-p
LAQLLARsPPPPHRP
0 2
EFS (human) LAQLLARsPPPPHRP S287-p
EFS iso2 (human) LAQLLARSPPPPHRP S194
EFS (mouse) VAQLPTRSSPPQHRP S286
EFS (rat) VAQLLTRSPPPQHRP S287
S298-p
PHRPRLPsAESLSRR
0 15
EFS (human) PHRPRLPsAESLSRR S298-p
EFS iso2 (human) PHRPRLPSAESLSRR S205
EFS (mouse) QHRPRLPsTEsLSRR S297-p
EFS (rat) QHRPRLPsTESLSRR S298-p
S301
PRLPsAESLSRRPLP
0 1
EFS (human) PRLPsAESLSRRPLP S301
EFS iso2 (human) PRLPSAESLSRRPLP S208
EFS (mouse) PRLPsTEsLSRRPLP S300-p
EFS (rat) PRLPsTESLSRRPLP S301
S317-p
LPVPEAPsPsPVPsP
0 2
EFS (human) LPVPEAPsPsPVPsP S317-p
EFS iso2 (human) LPVPEAPSPSPVPSP S224
EFS (mouse) LPVSEAPAPsPAPsP A316
EFS (rat) LPVSEAPAPSPAPSP A317
S319-p
VPEAPsPsPVPsPAP
Upstream
0 6
Treatment
  • LRRK2-IN-1
EFS (human) VPEAPsPsPVPsPAP S319-p
EFS iso2 (human) VPEAPSPSPVPSPAP S226
EFS (mouse) VSEAPAPsPAPsPAP S318-p
EFS (rat) VSEAPAPSPAPSPAP S319
S323-p
PsPsPVPsPAPGRKG
Upstream
0 6
Treatment
  • LRRK2-IN-1
EFS (human) PsPsPVPsPAPGRKG S323-p
EFS iso2 (human) PSPSPVPSPAPGRKG S230
EFS (mouse) PAPsPAPsPAPGRKG S322-p
EFS (rat) PAPSPAPSPAPGRKG S323
S331-p
PAPGRKGsIQDRPLP
Upstream
0 5
Treatment
  • LRRK2-IN-1
EFS (human) PAPGRKGsIQDRPLP S331-p
EFS iso2 (human) PAPGRKGSIQDRPLP S238
EFS (mouse) PAPGRKGSIQDRPLP S330
EFS (rat) PAPGRKGSIQDRPLP S331
Y372-p
PAGHHNEyEGIPMAE
0 3
EFS (human) PAGHHNEyEGIPMAE Y372-p
EFS iso2 (human) PAGHHNEYEGIPMAE Y279
EFS (mouse) PAGPHNEYEGIPMAE Y371
EFS (rat) SGGPHNEYEGIPMAE Y372
Y381-p
GIPMAEEyDyVHLKG
0 6
EFS (human) GIPMAEEyDyVHLKG Y381-p
EFS iso2 (human) GIPMAEEYDYVHLKG Y288
EFS (mouse) GIPMAEEYDYVHLKG Y380
EFS (rat) GIPMAEEYDYVHLKG Y381
Y383-p
PMAEEyDyVHLKGMD
0 6
EFS (human) PMAEEyDyVHLKGMD Y383-p
EFS iso2 (human) PMAEEYDYVHLKGMD Y290
EFS (mouse) PMAEEYDYVHLKGVD Y382
EFS (rat) PMAEEYDYVHLKGVD Y383